【レポートの概要（一部）】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Cystic Fibrosis Therapeutics Market Variables, Trends & Scope
3.1. Market Segmentation
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Key Opportunities Prioritized
3.4. Industry Analysis – Porter’s
3.5. Cystic Fibrosis Therapeutics Market-SWOT Analysis, By Factor (Political & Legal, Economic and Technological), 2015
Chapter 4. Cystic Fibrosis Therapeutics Market: Drug Class Estimates & Trend Analysis
4.1. Cystic Fibrosis Therapeutics Market Share by Drug Class, 2016 & 2025 (USD Million)
4.2. Pancreatic Enzyme Supplements
4.2.1. Market estimates and forecast, 2014 – 2025 (USD Million)
4.3. Mucolytics
4.3.1. Market estimates and forecast, 2014 – 2025 (USD Million)
4.4. Bronchodilators
4.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
4.5. CFTR Modulators
4.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
Chapter 5. Cystic Fibrosis Therapeutics Market: Route of Administration Estimates & Trend Analysis
5.1. Cystic Fibrosis Therapeutics Market Share by Route of Administration, 2016 & 2025 (USD Million)
5.2. Oral Drugs
5.2.1. Market estimates and forecast, 2014 – 2025 (USD Million)
5.3. Inhaled Drugs
5.3.1. Market estimates and forecast, 2014 – 2025 (USD Million)
Chapter 6. Cystic Fibrosis Therapeutics Market: Regional Outlook, by Drug Class and Route of Administration
6.1. Cystic Fibrosis Therapeutics Market Shares by Region, 2016 & 2025 (USD Million)
6.2. North America
6.2.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.2.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.2.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.2.4. U.S.
6.2.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.2.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.2.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.2.5. Canada
6.2.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.2.5.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.2.5.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.3. Europe
6.3.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.3.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.3.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.3.4. Germany
6.3.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.3.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.3.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.3.5. UK
6.3.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.3.5.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.3.5.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.4. Asia Pacific
6.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.4.4. China
6.4.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.4.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.4.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.4.5. Japan
6.4.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.4.5.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.4.5.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.5. Latin America
6.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.5.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.5.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.5.4. Brazil
6.5.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.5.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.5.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.5.5. Mexico
6.5.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.5.5.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.5.5.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.6. Middle East & Africa
6.6.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.6.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.6.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.6.4. South Africa
6.6.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.6.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.6.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
Chapter 7. Competitive Landscape
7.1. Strategic Framework
7.2. Company Profiles
7.2.1. AbbVie Inc.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. F. Hoffmann-La Roche Ltd
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Gilead
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Novartis AG
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Vertex Pharmaceuticals Incorporated
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. AIT (Advanced Inhalation Therapies)
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Alaxia
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Teva Pharmaceutical Industries Ltd.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Merck & Co. Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Alcresta Therapeutics, Inc.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. ALLERGAN
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. AstraZeneca
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
【レポート販売概要】
■ タイトル：嚢胞性線維症（CF）治療の世界市場分析■ 英文：Cystic Fibrosis (CF) Therapeutics Market Analysis By Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators), By Route of Administration, By Region, And Segment Forecasts, 2014 - 2025
■ 発行日：2017年6月2日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW70714001
■ 調査対象地域：グローバル
- 世界の養鶏機械市場（～2019）The expansion of the global poultry-keeping machine industry is forecast to reach 2.6% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 7.9%. Currently, poultry brooders and incubators account for 14.4% of the global demand while the remaining market share is divided between other poultry-keeping machines (59.7%) and parts for poultry-keeping ma …
- Ixekizumab (Psoriasis)：市場予測と分析（～2022）Ixekizumab (Psoriasis) - Forecast and Market Analysis to 2022 Summary Psoriasis is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2–3% worldwide (Perera et al., 2012). Specifically, adult plaque psoriasis is the focus of this report and is defined using the 2013 International Classification of Diseases, Tenth Revision, Clinical Modification (I …
- Market Opportunity: Call Continuity in Voice over LTE (VoLTE)Fourth generation (4G) data services are in the deployment stage, but is will be a few years until there is ubiquitous LTE coverage. Meanwhile, there are competitive threats emerging against incumbent carriers’ core voice services. This is coming at a time when all bearer services (voice and data) are becoming marginalized due to market expectations, economic conditions, and a coming supply side e …
- 高級化粧品の世界市場：オーガニック、従来型Cosmetics refer to products used to cleanse the skin and enhance the physical features of humans. These include products such as skincare, haircare, makeup, and fragrances. Since time immemorial, the human race has embraced altering their bodily aspects to enhance their self-esteem. Cosmetics play a vital role in complementing an individual’s inherent beauty and physical features. In the twenty-fi …
- 国土セキュリティ用監視カメラの世界市場2017-2021About Homeland Security Surveillance Camera Surveillance cameras monitor the behavior and activities of people for the purpose of managing, directing, or protecting them. Electronic systems, such as the closed-circuit television (CCTV), are generally used to perform surveillance from a distance. These cameras are primarily used by various governments and government agencies for intelligence gather …
- 通信用タワーの世界市場2019-2023Global Telecom Tower Market: About this market Technavio’s telecom tower market analysis considers sales from operator-led tower companies, mobile network operators (MNO) captive sites, independent tower companies, and joint venture infrastructure companies. Our analysis also considers the sales of telecom tower in APAC, Europe, North America, South America, and MEA. In 2018, the operator-led towe …
- 世界の受動光ネットワーク(PON)装置市場2015The Global Passive Optical Network (PON) Equipment Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Passive Optical Network (PON) Equipment industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Passive Optical Network (PON) Equipment market analysis is …
- 世界のシェールガス処理装置市場動向と予測（～2019）This report estimates the shale gas processing equipment market, in terms of value. The value of this market is estimated in terms of $million and this has been broken down into geographical regions, and further split into processing components. Shale gas processing equipment are required for processing shale gas before it can be transported by large diameter inter-state or intra-state pipelines f …
- アメリカのスマートフォン用音声認識市場Voice recognition is a type of authentication technology where sounds, words, or phrases spoken by humans are converted into electrical signals with assigned meanings. In this market research report, Technavio analysts estimate the voice recognition market in the US to surpass USD 601 million by 2019 owing to its augmented application in sending mails, messages, and we search. Growing popularity o …
- 半導体IPの世界市場：プロセッサIP、フィジカルIP、デジタルIPAbout Semiconductor IP Semiconductor IP is an integral part of electronic design and automation (EDA) process and are meant to aid design engineers and developers to develop new chips. The use of semiconductor IP blocks in lieu of the miniaturization of electronic products reduces the overall production cost. The growing complexity of semiconductor chip designs is adding to the importance of semic …
- 後発医薬品の世界市場：機会、課題、戦略、市場予測A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive rights. Already prevalent in the U.S., Europe and much of the developing world, generic drugs are now finding their way into previously untapped markets suc …
- 脱臭システムの世界市場予測（～2023年）“The deodorization systems market is projected to grow at a CAGR of 4.9%; the key drivers include growth in the edible oils industry, growing demand for higher nutritional value in edible oils, and the technological developments to overcome process limitations.” The deodorization systems market is estimated at USD 3.4 billion in 2018 and projected to grow at a CAGR of 4.9%, to reach USD 4.3 billio …
- スタチンの世界市場：ロバスタチン、プラバスタチン、シンバスタチン、アトルバスタチン、フルバスタチン、ロスバスタチンAbout Statin Statin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in cholesterol synthesis, which is called HMG-CoA reductase. Therefore, statin is referred to HMG-CoA reductase inhibitors. Statin has been associated with a beneficial effect on cardiovascular morbidity and mortality. It has signif …
- マイクロ流体のグローバル市場動向The healthcare segment is featured with microfluidic applications which refers to the flow of biological liquids through micro channels ranging from nanolitres to few picoltres. This newest approach adds several benefits to the medical world, such as large surface to volume ratio, less reagent consumption, quick diagnosis and high accuracy of the results. Thus, the emerging field of ‘microfluidics …
- 産業向け埋込みシステムの世界市場2016-2020：ハードウェア、ソフトウェアAbout Industrial Embedded Systems Integrated circuits and microchips have revolutionized industrial automation. The earliest example of a single board single purpose design is the PC/104, which had accessory boards to accommodate many application needs, but was as large as a 3.5-inch floppy disk. Chip manufacturers subsequently improvised and developed single board systems with smaller processors …
